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traction (EC) coupling, the process by which electricalAlternative Splicing Regulation
stimulation results in physical contraction. Isolated cellsImpacts Heart Development exhibited several features indicative of Ca2mishandling
and consistent with an EC coupling defect. The chal-
lenge was to determine the molecular basis for these
abnormalities and to make the connection to the loss
SR proteins serve multiple roles in the posttranscrip- of ASF/SF2. The majority of alternative splicing events
tional control of gene expression, including as regula- examined were unaffected in ASF/SF2-deficient hearts,
tors of alternative splicing. In this issue of Cell, Xu et but three were shown to be altered. One was Ca2/
al. (2005) demonstrate that a heart-specific knockout calmodulin-dependent kinase II  (CaMKII), a regulator
of oneSRprotein, ASF/SF2, produces cardiomyopathy of ECcoupling. Between1 and 2months of age, CaMKII
and misregulation of specific alternative splicing normally undergoes an alternative splicing transition in
events during early postnatal development. heart from two cardiac and one neuronal isoforms to
just the cardiac isoforms. During postnatal development
of ASF/SF2-deficient hearts, however, an abnormal tran-The frequency of alternative splicing (50% of human
sition occurs in which the adult cardiac isoforms disap-genes) as well as the potential number of protein iso-
pear and the adult neuronal isoform becomes predomi-forms expressed from individual genes (into the thou-
nant. Is the EC coupling defect due to loss of the normalsands) underlie a recently appreciated source of pro-
adult cardiac isoforms or a gain of function of the inap-teome diversity. While the potential number of proteins
propriate neuronal isoform? The authors demonstratedgenerated is remarkable, the greater significance of al-
the latter to be the case since ectopic cardiac-specificternative splicing is in the ability to regulate the expres-
expression of the neuronal CaMKII isoform in wild-typesion of functionally diverse (even antagonistic) proteins
mice produced a partial phenocopy of the ASF/SF2-from single genes according to cell type, developmental
deficient mice; in particular, isolated cardiomyocytesstage, or in response to acute stimuli. Controlling the
exhibited the same Ca2 handling defects as ASF/SF2-expression of protein isoforms is not the only output of
deficient cells. The different CaMKII isoforms exhibitalternative splicing; 20% of the resulting mRNA variabil-
similar catalytic and regulatory activities but differ inity is within untranslated regions (Modrek et al., 2001)
their intracellular localization (Bayer and Schulman,which commonly contain elements that regulate transla-
2001). The basis for the defect in ASF/SF2-deficienttion, mRNA stability, or localization. As many as one
cardiomyocytes might be refreshingly straightforwardthird of alternative splicing events insert premature ter-
in that the neuronal isoform mislocalizes to T-tubulesmination codons that usually result in mRNA degrada-
where CaMKIImodulates EC coupling. Caveats of pro-tion by nonsense-mediated decay, providing a mecha-
tein overexpression aside, the results very nicely link
nism for on/off regulation (Lewis et al., 2003). These
the phenotype to a specific splicing defect.
observations demonstrate that alternative splicing is
ASF/SF2-deficient hearts progress from no overt pa-
firmly integrated into the regulatory circuitry of gene thology at 3 weeks postnatally to dilated cardiomyopa-
expression. To understand the details of this integration, thy by 7 weeks and death before 10 weeks. The timing of
work in the field is progressing rapidly to characterize the altered splicing transitions in the ASF/SF2-deficient
the extent of “functional” alternative splicing, the factors hearts correlates with this pathology. Cre-mediated in-
that directly regulate splice site selection, the upstream activation of the ASF/SF2 gene is expected to initiate
signaling events that modify the activities of the regula- much earlier (embryonic day 8.5), suggesting that a criti-
tors, and the downstream physiological consequences cal requirement for ASF/SF2 is not apparent until several
of the different protein and mRNA isoforms expressed. weeks after birth. The authors propose that ASF/SF2
Biochemical and transfection approacheshave identi- plays a major regulatory function during this period in
fied a largenumber of RNAbindingproteins that regulate which there are various physiological transitions and
splicing in vertebrates via binding to specific motifs ad- stresses on heart function. Their results highlight the
jacent to regulated splice sites (Black, 2003). One family huge potential and largely unexplored role for alternative
is the SR proteins, which are highly conserved and have splicing during vertebrate development. While several
dual roles in constitutive and regulated splicing (Gra- changes in gene expression, both transcriptional and
veley, 2000). Individual SR proteins have unique binding posttranscriptional, are associated with early postnatal
specificities; however, they bind to exonic elements heart development, the extent of these changes relative
common among constitutive and alternative exons. This to other developmental periods remains to be fully char-
plus the fact that they are required for splicing in cell- acterized. Large-scale analysis by emerging DNA mi-
free assays suggest that SR proteins have the potential croarray technologies will provide a foundation for a
to influence splicing of most if not all pre-mRNAs. systematic assessment of the breadth of alternative
Strikingly, Xu et al. demonstrate that the heart-specific splicing transitions throughout normal development and
knockout of one SR protein, ASF/SF2, results in severe for the comparative analysis of splicing in ASF/SF2-
cardiomyopathy and disruption of only a subset of alter- deficient and wild-type hearts.
native splicing events. Physiological analysis of isolated The effects of ASF/SF2 depletion on the three misreg-
ulated splicing patterns reveals the complexities associ-cardiomyocytes identified a defect in excitation-con-
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heart development, switched to the skeletal muscle iso-
form. Current models indicate that cell-specific splicing
in vertebrates results from the repression of cell-specific
patterns in inappropriate cell types and activation in the
appropriate cell types (Black, 2003). It is not surprising UPS Shipping and Handling
that disruption of this balance results in the appearance
of inappropriate, and perhaps competing, splicing pat-
terns.
It remains to be determined whether the three misreg- It is now clear that the two broad sets of reactions in
the ubiquitin-proteasome system (UPS), the conjuga-ulated pre-mRNAs are direct targets of ASF/SF2 in that
responsiveness to ASF/SF2 is mediated via direct RNA- tive and degradative steps, are intricately coupled
in vivo and that there are numerous factors that aidprotein interactions. Given the recently identified roles
for ASF/SF2 in mRNA export, mRNA stability, and trans- in the handling and delivery of ubiquitylated proteins
to the proteasome. The report from Richly et al. (2005lation (Sanford et al., 2004 and references within), it
is possible that loss of ASF/SF2 affects expression of [this issue ofCell]) suggests how several of the known
players in this process might work together in guidingproteins that bind and regulate one or more of these
pre-mRNAs. Either way, the new results establish a criti- and delivering some substrates to their final destina-
tions.cal role for ASF/SF2 in maintaining appropriate cell-
specific splicing patterns of specific pre-mRNAs. Fur-
ther investigation will reveal its explicit role(s) along the The UPS is a major route for regulated protein destruc-
continuum of what is likely to be a regulatory cascade. tion in eukaryotic cells and is central to the regulation
Fu and colleagues (Xu et al., 2005) also demonstrated of an astounding array of biological pathways. Ubiquitin
that splicing abnormalities observed in ASF/SF2-defi- is covalently conjugated to target proteins in the form
cient hearts were not observed in hearts deficient for of specific types of polyubiquitin chains, anchored on
another SR protein, SC35 (Ding et al., 2004), demonstra- one or more lysine side chains of the target protein. The
ting clear and important functional differences between enzymes that catalyze ubiquitin conjugation are thewell-
these two SR proteins. characterized E1 and E2 enzymes, along with the much
This and other recent studies (Ding et al., 2004; Jensen more numerous and diverse E3 enzymes. A fourth group
et al., 2000; Kanadia et al., 2003)mark a newand exciting of enzymes, the E4 enzymes, typified by yeast Ufd2,
direction for investigations of splicing regulation in ver- have been previously shown by Jentsch and coworkers
tebrates. The field is wide open, the tools are available, to recognize short ubiquitin chains and catalyze their
and the analysis of “functional” alternative splicing is extension (Koegl et al., 1999). The 26S proteasome inter-
just beginning. acts with polyubiquitylated proteins and in a concerted
series of events removes the ubiquitin moieties, unfolds
the target proteins, and translocates the target protein
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